Taiwan News

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial

Highlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating ...

First participant dosed with Neurizon’s lead drug candidate in landmark HEALEY ALS trial

The first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon Therapeutics’ lead ...
Business Wire

HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients were enrolled in their novel prospective master protocol ...
ascopubs.org

Master Protocol Design With Hybrid Control for Efficient Early-Phase Trial Consolidation

Timing of Adjuvant Chemotherapy After Gastrectomy in Patients With Stage II to III Gastric Cancer: A Target Trial Emulation Study Master protocols represent transformations, enabling multiple ...
ascopubs.org

Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN)

Biomarker-driven master protocols represent a new paradigm in oncology clinical trials, but their complex designs and wide-ranging genomic results returned can be difficult to communicate to ...